Table 5c.

Treatment of Manifestations in Individuals with Cystic Fibrosis

Manifestation/
Concern
TreatmentConsiderations/Other
Pulmonary Airway clearance to aid in mucus clearance 1
Chronic pulmonary medications to open airway, ↓ sputum viscosity, promote expectoration of secretions, & deliver anti-inflammatory & antimicrobial medications 2Recommended sequence for inhaled medications:
  • Bronchodilator
  • Hypertonic saline
  • Dornase alfa
  • Airway clearance
  • Inhaled corticosteroids &/or long-acting beta agonist (for select persons)
  • Aerosolized antibiotic
Standard treatments for pneumothorax or hemoptysis 3
Consider double lung transplant for those w/advanced lung disease. 4
Infection Routine childhood vaccinations incl annual influenza vaccine
Use contact precautions (gown & gloves) for every encounter by every clinician.Assume all people w/CF have transmissible bacteria.
  • Antibiotics (oral, inhaled, or IV) for chronic suppression & to treat pulmonary exacerbations
  • Treat identified bacteria in affected persons & bacteria common in CF. 5
Eradication attempts are recommended for Pseudomonas aeruginosa6
ENT
  • Standard treatments for rhinosinusitis
  • Referral to ENT specialist w/CF experience as needed
  • Sinus surgery as needed to widen ostia &/or clear impacted secretions
  • Polypectomy as needed for obstructive nasal polyps
If needed, evaluate w/sinus CT; but often reserved for pre-surgical planning or unresolved symptoms despite maximal therapy.
Exocrine
pancreatic
insufficiency
  • Consult w/nutritionist w/experience in CF.
  • Pancreatic enzyme replacement therapy
  • Nutrient-dense food & supplements
  • Fat-soluble vitamin supplements
  • Consider zinc supplementations.
  • Consider gastrostomy tube. 7
Distal intestinal
obstructive
syndrome
  • If obstructed, consult w/surgeon for intervention.
  • If not obstructed, use laxatives. 8
Gastroesophageal
reflux disease
Standard treatments
Liver disease
  • Persistent elevations in liver function tests are treated w/ursodiol. 9
  • Refer to hepatologist w/CF experience.
May progress to need for liver transplant.
Diabetes (CFRD)
  • Refer to endocrinologist familiar w/CFRD.
  • Treat CFRD w/glucose monitoring & insulin therapy. 10
Infertility Invasive procedures & cost of aspiration/extraction followed by IVF may be prohibitive for many. 11
Males:
  • Ultrasound to assess for absence of vas deferens
  • ART involves eval by urologist. 2 techniques are widely used: microsurgical epididymal sperm aspiration or testicular biopsy & sperm extraction.
  • Once sperm is obtained, IVF w/intracytoplasmic sperm injection is necessary as sperm counts & concentration are often too low for intrauterine insemination. 11
Female partners of men w/CF will also need to undergo medical procedures assoc w/IVF regardless of underlying fertility status.
Females:
  • ↓ fertility or infertility can be treated by several options available through ART. 12 There are no currently established guidelines as to which modality should be used.
  • While intrauterine insemination combined w/gonadotropin ovulation induction can be used, IVF is more co mmonly used. 11
IVF offers ability of preimplantation genetic testing.
Salt loss
syndromes /
Dehydration
  • Salt supplementation
  • Extra salt & water for hydration & salt loss in situations w/salt loss (e.g., ↑ heat/humidity, exercise)
Mental health Standard treatments using age-appropriate psychotherapy & pharmacotherapy 13

From: Cystic Fibrosis

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.